CEO Corner

Alessandro Riva, M.D. is a first-time biotech CEO who shares some of the values and leadership strategies he has learned over the years, including how to foster a culture of relentless innovation.

If patients are always at the heart of why we do what we do, then why do they feel that pharmaceutical companies don’t truly understand their needs?

Walter Klemp, CEO of Moleculin, shares several lessons he learned from his consumer-product background.

When it comes to achieving success, a few commonalities have crystallized for me during my 30+ years in the pharma industry. Here I share five key tenets that I have found critical to success over the arc of my career.

Thirty-year pharma veteran Nancy Lurker shares her four pillars on which to build your business and why they are crucial to driving stakeholder value over the mid- to long-term.

To address the opioid epidemic we need an all-out national prevention effort akin to the one that finally began to slow the AIDS epidemic in the 1990s. Here are four actions that could help “unlock” the problem.

“Looking back on my 25 years in academic medical research, I can’t think of a single learning experience that equipped me for the world of entrepreneurship, running a public company, or interacting with the capital markets.”

Being the founder and CEO of SQZ Biotech is actually Armon Sharei’s first full-time job. He warns that although people often applaud entrepreneurship, lionize its leaders, and paint it as a glamorous adventure, that isn’t really what it’s like.  

Can German, American, Chinese, and other companies worldwide work together to advance the mRNA revolution and possibly launch the new “pharmacy of the world?”

While there are many key aspects of a successful international collaboration across many time zones and great distance, in our experience — a collaboration between organizations based in the U.S. and Japan — there are a few essential elements.